Projected lives saved and economic value of mRNA cancer immunotherapies in the United States.

Wells CR, Pandey A, Bawden C, Ye Y, Bilori B, Potter-Schwartz L, Ayaz L, Moghadas SM, Townsend JP, Fitzpatrick MC, Galvani AP

Open source

DOI: 10.1016/j.lana.2026.101596
Published: 2026 Oct
Container: Lancet regional health. Americas
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lana.2026.101596,
  title = {Projected lives saved and economic value of mRNA cancer immunotherapies in the United States.},
  author = {Wells CR and Pandey A and Bawden C and Ye Y and Bilori B and Potter-Schwartz L and Ayaz L and Moghadas SM and Townsend JP and Fitzpatrick MC and Galvani AP},
  year = {2026},
  journal = {Lancet regional health. Americas},
  doi = {10.1016/j.lana.2026.101596},
  url = {https://doi.org/10.1016/j.lana.2026.101596}
}

RIS

TY  - JOUR
TI  - Projected lives saved and economic value of mRNA cancer immunotherapies in the United States.
AU  - Wells CR
AU  - Pandey A
AU  - Bawden C
AU  - Ye Y
AU  - Bilori B
AU  - Potter-Schwartz L
AU  - Ayaz L
AU  - Moghadas SM
AU  - Townsend JP
AU  - Fitzpatrick MC
AU  - Galvani AP
PY  - 2026
JO  - Lancet regional health. Americas
DO  - 10.1016/j.lana.2026.101596
UR  - https://doi.org/10.1016/j.lana.2026.101596
ER  -

APA

CR, W., A, P., C, B., Y, Y., B, B., L, P., L, A., SM, M., JP, T., MC, F., & AP, G. (2026). Projected lives saved and economic value of mRNA cancer immunotherapies in the United States.. Lancet regional health. Americas. https://doi.org/10.1016/j.lana.2026.101596

Source records

pubmed · retrieved 2026-09-26T20:21:39.143Z